about
Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gammaPPAR-gamma: Therapeutic Potential for Multiple SclerosisHonokiol: a non-adipogenic PPARγ agonist from naturePPARs and the cardiovascular systemCaveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in AtherosclerosisNovel mechanisms of endothelial mechanotransductionEndothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceInflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical ExerciseMinireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolismInverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasionThe role of PPARγ in carbon nanotube-elicited granulomatous lung inflammationGenomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Transduction of redox signaling by electrophile-protein reactionsNuclear receptors as drug targets for metabolic disease.PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression.Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile responseGenome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency.Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control studyPPARalpha: energy combustion, hypolipidemia, inflammation and cancerPRIC295, a Nuclear Receptor Coactivator, Identified from PPARα-Interacting Cofactor ComplexAiming drug discovery at lysophosphatidic acid targets.PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytesIn vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancerIdentification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsTrans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytesIntegrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosisRecombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosisArginine decreases peroxisome proliferator-activated receptor-γ activity via c-Jun.Formation and signaling actions of electrophilic lipidsN-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.Age-associated chronic diseases require age-old medicine: role of chronic inflammation.
P2860
Q21090765-F68682BE-0657-445D-99D1-E17C29FC22DFQ21342822-A16E47D7-85B7-4BB8-BD74-113C3092DF49Q24614114-E7201B3A-7FE2-4874-9186-21022C997844Q24642728-90640843-01DF-4A0F-B5B8-C87399298B9EQ26752101-16C88E02-A6FE-422F-9300-00C8947A30E9Q27022880-978E885C-E3C9-4049-8EB8-F51E01E4C8CAQ27342480-400F3F75-E7B1-4483-BDB9-C4D2EC6F5DBFQ28076878-A77E2D2A-602F-4B86-BF78-60BB45D11C22Q28084780-E8F54B99-A47B-44D5-88DD-B23D6818C917Q28280615-FFD89EE8-215A-4561-9F18-14FCCD2156B8Q28393864-0F08D7A3-E2E2-45CE-9806-88BD324F2317Q28476779-090B299C-D5B9-4AC8-BC93-825AABEA0B76Q30381222-C0A0651C-CDBC-46D6-8EA9-85DD80931CF8Q30430126-36A66363-20C5-4E34-BD51-05C864396AEFQ33335961-9136636C-571D-4BA4-9262-06D58D29B0F8Q33339707-A38ED3F3-C610-4A9F-91A8-7C23EF75A76EQ33493427-FC2534FF-8A22-4CF4-A09D-AC53C6137257Q33585657-5B338DB5-1735-453B-AAA6-19D682106237Q33621757-BBA7E0C1-0B5F-4F3A-B039-2F927BB4DAA4Q33642155-AD07B2E3-2E05-459A-BCA1-16241932CD85Q33683897-8A66C42B-80DF-4C1C-B039-04B4D499C547Q33791893-A46BFE92-08B8-49BF-8472-53DE3BEC3C34Q33805104-D85EC8C0-0C2C-4F89-8FC6-E70BEC31BB7EQ34159503-39EAECCC-74C7-4F4D-9783-910D38C3F6B0Q34339759-210C886C-6D89-419E-9BB8-ED5F4D14A550Q34374048-1F46FF38-281B-42D1-A8EE-21EB86906DA2Q34501727-F14A6A3C-F5B6-43A9-BD6C-9FFE9EBEB5D8Q34522002-31071ED4-833D-44C1-9A57-691AD0BE246EQ34949771-2BC26B03-D298-40A5-87A3-53B08B39A02BQ35168034-B8BED30F-9EBE-48D3-9F27-271E17903FC0Q35237706-28A8134D-42F4-4BB1-A277-961EB2051904Q35274791-73B537FC-7981-430C-835B-A3EFB7DB5096Q35464823-BE7625CB-0609-4EAC-A795-61AE1E945E6DQ35569436-84AA7BCE-22B1-4FD1-A5B4-57C72A307FB4Q35643703-F76BD7E9-4EED-414D-9A4C-56A3DE111629Q35685450-44E98FA4-4EE5-4594-830A-76D761458693Q35722757-21014959-3215-4BA1-AD6F-27E478C3EC57Q35804051-DD644B35-C29D-4FA3-886E-A1E958819582Q35842216-0EC5E1B2-1FC7-4F0B-AB7C-6259B2F451EBQ35923150-CF7B7A19-CEB5-4426-9023-38D289E644FB
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
PPARs and molecular mechanisms of transrepression
@ast
PPARs and molecular mechanisms of transrepression
@en
type
label
PPARs and molecular mechanisms of transrepression
@ast
PPARs and molecular mechanisms of transrepression
@en
prefLabel
PPARs and molecular mechanisms of transrepression
@ast
PPARs and molecular mechanisms of transrepression
@en
P2860
P1476
PPARs and molecular mechanisms of transrepression
@en
P2093
Christopher K Glass
P2860
P304
P356
10.1016/J.BBALIP.2007.02.013
P407
P577
2007-03-12T00:00:00Z